DrugPatentWatch Database Preview
ERGOMAR Drug Profile
or, see our see our flat-rate plans
When do Ergomar patents expire, and what generic alternatives are available?
The generic ingredient in ERGOMAR is ergotamine tartrate. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ergotamine tartrate profile page.
Summary for ERGOMAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 13 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,884 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ERGOMAR at DailyMed |
Pharmacology for ERGOMAR
| Ingredient-type | Ergotamines |
| Drug Class | Ergotamine Derivative |
Medical Subject Heading (MeSH) Categories for ERGOMAR
Synonyms for ERGOMAR
| (4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide |
| (4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0;{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide |
| (5''alpha)-12''-hydroxy-2''-methyl-5''-(phenylmethyl)ergotoman-3'',6'',18-trione |
| (5''alpha)-5''-benzyl-12''-hydroxy-2''-methyl-3'',6'',18-trioxoergotaman |
| (5'A)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman 2,3-dihydroxybutanedioate(2:1) |
| (5'alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione |
| (5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman |
| 1080650-16-3 |
| 113-15-5 |
| 12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione |
| 12''-hydroxy-2''-methyl-5''alpha-(phenylmethyl)ergotaman-3'',6'',18-trione |
| 379-79-3 (2:1 tartrate salt) |
| 6915-20-4 |
| 98260-30-1 |
| AB01275473-01 |
| AC1L1QJJ |
| AKOS015896505 |
| Ambotz113-15-5 |
| Avetol |
| BDBM50027065 |
| BRN 0078890 |
| C33H35N5O5 |
| CHEBI:64318 |
| CHEMBL442 |
| Cornutamin |
| Cornutamine |
| D01TSI |
| D07906 |
| DB00696 |
| DTXSID9043774 |
| EINECS 204-023-9 |
| Ergam |
| Ergate |
| Ergomar (TN) |
| Ergonsvine |
| Ergostat |
| Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)- |
| Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-(9CI) |
| Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)- |
| Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt) |
| Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) |
| Ergotamin |
| Ergotamina |
| Ergotamina [INN-Spanish] |
| ERGOTAMINE |
| Ergotamine (INN) |
| ERGOTAMINE (SEE ALSO: ERGOTAMINE TARTRATE (CAS 379-79-3)) |
| Ergotamine [INN:BAN] |
| Ergotamine bitartrate |
| Ergotamine hemitartrate |
| ergotamine tartrate |
| Ergotamine tartrate (VAN) |
| Ergotamine tartrate, Avetol, Cornutamin, Ergam, Ergotartrate |
| Ergotamine, tartrate (2:1) |
| Ergotamine, tartrate (2:1) (salt) (8CI) |
| ergotaminum |
| Ergotaminum [INN-Latin] |
| Ergotartrate |
| Ergoton-A |
| ERM |
| ETIN |
| Exmigra |
| Femergin |
| Gotamine tartrate |
| GTPL149 |
| Gynergen |
| HMS2089H22 |
| HSDB 4076 |
| I06-2464 |
| Lingraine |
| Lingran |
| LS-564 |
| Medihaler ergotamine |
| Migretamine |
| N-[(2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-methyl-[?]carboxamide |
| Neo-ergotin |
| NSC 95090 |
| PR834Q503T |
| Rigetamin |
| SCHEMBL1483 |
| Secagyn |
| Secupan |
| Temigran |
| TX-012337 |
| UNII-PR834Q503T |
| Wigrettes |
| ZINC52955754 |
US Patents and Regulatory Information for ERGOMAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera Theraps Llc | ERGOMAR | ergotamine tartrate | TABLET;SUBLINGUAL | 087693-001 | Feb 24, 1983 | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
